Trials / Recruiting
RecruitingNCT07160036
Repeatability of AO-SLO (Mona IIa) Technology and Cone Cell Density of Individuals Use Repeated Low-level Red-light Therapy
Exploring the Repeatability of Adaptive Optics Scanning Laser Ophthalmoscope Technology (AO-SLO Mona IIa) and the Differences in Cone Cell Density Between Individuals Who Undergone and Not Undergone Repeated Low-level Red-light
- Status
- Recruiting
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 180 (estimated)
- Sponsor
- Ruihua Wei · Academic / Other
- Sex
- All
- Age
- 6 Years – 55 Years
- Healthy volunteers
- Not accepted
Summary
To explore the repeatability of AO-SLO (Mona IIa) technology and the difference of cone cell density between individuals who used or not used repeated low-intensity red light treatment
Detailed description
This study focuses on the population with long-term use of repetitive low-intensity myopia, exploring the safety of repetitive low-intensity red light over a long period of use, and providing data support and clinical guidance for the field of repetitive low-intensity red light. It investigates the repeatability of adaptive optics scanning laser ophthalmoscope technology and observes the safety of repetitive low-intensity red light treatment for children over a long period of use.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DEVICE | RLRL(Model RS-200-2A, Eyerising; Suzhou Xuanjia Optoelectronic Technology Co., Ltd., Suzhou, China)) | use RLRL twice a day |
Timeline
- Start date
- 2025-09-20
- Primary completion
- 2025-11-20
- Completion
- 2025-12-20
- First posted
- 2025-09-08
- Last updated
- 2025-09-15
Locations
1 site across 1 country: China
Source: ClinicalTrials.gov record NCT07160036. Inclusion in this directory is not an endorsement.